Impact of High Dose Early Mobilization on Outcomes for Patients with Diabetes: A Secondary Analysis of the TEAM Trial.
Ary Serpa NetoMichael BaileyDaniel SellerAlicia AgliRinaldo BellomoKathy BrickellTessa BroadleyHeidi BuhrBelinda J GabbeDoug W GouldMeg HarroldAlisa M HigginsSally HurfordTheodore J IwashynaAlistair D NicholJeffrey J PresneillStefan J SchallerJanani SivasuthanClaire J TippingAlex PooleRachael ParkeScott BradleySteven WebbSophia ZoungasPaul Jeffrey YoungCarol L HodgsonPublished in: American journal of respiratory and critical care medicine (2024)
In this secondary analysis of the TEAM trial, in patients with diabetes, a high dose early mobilization strategy did not significantly decrease the number of days alive and out of hospital at day 180 but it increased 180-day mortality.
Keyphrases
- high dose
- low dose
- stem cell transplantation
- study protocol
- phase iii
- palliative care
- clinical trial
- phase ii
- quality improvement
- healthcare
- cardiovascular events
- type diabetes
- randomized controlled trial
- risk factors
- coronary artery disease
- metabolic syndrome
- emergency department
- adverse drug
- skeletal muscle
- insulin resistance
- drug induced